Protalix BioTherapeutics, Inc. Annual Return On Assets in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Protalix BioTherapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2012 to 2023.
  • Protalix BioTherapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -11.7 %, a 182% decline year-over-year.
  • Protalix BioTherapeutics, Inc. annual Return On Assets for 2023 was 10.2 %.
  • Protalix BioTherapeutics, Inc. annual Return On Assets for 2022 was -24.7 %, a 17.5% increase from 2021.
  • Protalix BioTherapeutics, Inc. annual Return On Assets for 2021 was -30 %, a 239% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 10.2 +34.9 Jan 1, 2023 Dec 31, 2023
2022 -24.7 +5.25 +17.5% Jan 1, 2022 Dec 31, 2022
2021 -30 -21.1 -239% Jan 1, 2021 Dec 31, 2021
2020 -8.85 +25.1 +73.9% Jan 1, 2020 Dec 31, 2020
2019 -33.9 +9.54 +21.9% Jan 1, 2019 Dec 31, 2019
2018 -43.5 +82.9 +65.6% Jan 1, 2018 Dec 31, 2018
2017 -126 -89.5 -243% Jan 1, 2017 Dec 31, 2017
2016 -36.8 -116 -147% Jan 1, 2016 Dec 31, 2016
2015 78.8 +112 Jan 1, 2015 Dec 31, 2015
2014 -33 -2.66 -8.78% Jan 1, 2014 Dec 31, 2014
2013 -30.3 -15.3 -101% Jan 1, 2013 Dec 31, 2013
2012 -15.1 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.